Comparative study of the inhibitory effect on bone erosion progression with Denosumab treatment and conventional treatment in rheumatoid arthritis patients. An open label randomized controlled trial by HR-pQCT.
Phase of Trial: Phase II
Latest Information Update: 18 Jul 2018
At a glance
- Drugs Denosumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Daiichi Sankyo Company
- 09 Jul 2018 Status changed from not yet recruiting to recruiting.
- 03 Jan 2018 New trial record